Radiofrequency catheter ablation of atrial tachycardia and atrial flutter.

Published on Jan 1, 1996in Coronary Artery Disease1.439
Simons Gr1
Estimated H-index: 1
,
Wharton Jm1
Estimated H-index: 1
Sources
Abstract
ūüďĖ Papers frequently viewed together
References0
Newest
Cited By5
Newest
Aims To analyse whether heart rate may affect the efficacy of adenosine, verapamil and carotid sinus massage in terminating symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) in adults. Methods and results The study population was selected among 175 adult patients, affected by symptomatic PSVT. One hundred and six of them were considered eligible for the study. Each subject received one of the following treatments: verapamil, 5 mg intravenously (IV) in 5‚Äď10 min, followed by 1...
Source
These practice guidelines are intended to assist physicians in clinical decision making by describing a range of generally acceptable approaches for the diagnosis and management of supraventricular arrhythmias. These guidelines attempt to define practices that meet the needs of most patients in most
Source
#2Melvin M. ScheinmanH-Index: 100
Last. Sidney C. SmithH-Index: 10
view all 4 authors...
#1Ruey J. Sung (Stanford University)H-Index: 18
#2Michael R. Lauer (Stanford University)H-Index: 11
Atrial tachyarrhythmias are defined as supraventricular tachyarrhythmias that do not require the AV node or ventricular tissue for initiation and maintenance. Therefore, this definition excludes AV junctional tachycardia, AV nodal reentrant tachycardia, and AV reciprocating tachycardia involving an accessory AV connection. These arrhythmias are discussed in detail elsewhere (‚ÄúAtrioventricular Nodal Reentrant Tachycardia‚ÄĚ on page 487 and ‚ÄúVentricular Preexcitation Syndromes: The Wolff-Parkinson-W...
Source
#1Ivan S. Lambińá (University of Belgrade)
Summary. Antiarrhythmic therapy can have a key role in prolonging the lives of patients with most common atrial tachyarrhythmias such as atrial flutter (AFL) or atrial fibrillation (AF). The optimal use of antiarrhytmic drug therapy depends in part on understanding the underlying mechanisms of AFL and AF and pharmacodynamis of each antiarrhythmic drug. Currently, there is a large body of experimental and clinical evidence that documents that AFL is associated with a macro-reentry mechanism assoc...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.